Abstract
Cholestatic liver disease encompasses a detrimental group of diseases that are non-discriminatory in nature. These diseases occur over every age range from infancy (biliary atresia) to geriatrics (hepatitis). They also cover both genders in the form of primary sclerosing cholangitis in men and primary biliary cholangitis in women. Oftentimes, owing to the disease progression and extensive scarring, the treatment of last resort becomes a liver transplant. In this review, we will briefly discuss and explore new avenues of understanding in the progression of cholestatic liver disease and possible therapeutic targets for intervention. The greater our understanding into the idiopathic nature of cholestatic liver disease, the better our chances of discovering treatment options to halt or reverse the progression, reducing or eliminating the need for expensive and risky transplants.
Subject
General Pharmacology, Toxicology and Pharmaceutics,General Immunology and Microbiology,General Biochemistry, Genetics and Molecular Biology,General Medicine
Reference35 articles.
1. Biology of Cholangiocytes: From Bench to Bedside.;K Yoo;Gut Liver.,2016
2. Adaptive remodeling of the biliary architecture underlies liver homeostasis.;K Kaneko;Hepatology.,2015
3. Transport systems in cholangiocytes: their role in bile formation and cholestasis.;M Strazzabosco;Yale J Biol Med.,1997
4. Liver and Gallbladder;V Kumar,2015
5. Bile duct ligation in mice: induction of inflammatory liver injury and fibrosis by obstructive cholestasis.;C Tag;J Vis Exp.,2015
Cited by
3 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献